CB1R gene deletion, CB1R siRNA or CB1R antagonists (AM6545, SR141716, given at pre-diabetic stage) was shown to attenuate the indicators of nephropathy [253,254,255,256]. This evidence concerns the gene CNR1 and kidney disorder.